World Health Organisation. The World Health Report 1997. Geneva: WHO; 1997.
2.
This important annual review of the world health situation summarises the latest estimates of the global burden of disease.
3.
StallonesRA. The rise and fall of ischemic heart disease. Scientific American1980;243: 43–49.
4.
This historical overview of the origins and evolution of the CHD epidemic in the USA uses the broader category diseases of the heart' to overcome problems caused by changes in diagnostic, certification and coding practices. This paper is the most convincing documentation of the origin of the CHD mortality epidemic in the USA in 1920s.
5.
UemuraKPisaZ. Trends in cardiovascular disease mortality in industrialised countries since 1950. World Health Stat Q1988; 41: 165–178.
6.
OsmondC. Coronary heart disease mortality trends in England and Wales, 1952–1991. J Publ Health Med1995; 17: 404–410.
7.
This paper examines the contributions of period (cross-sectional) and cohort (generation) effects to the CHD mortality trends in England and Wales. The analysis concludes that CHD death rates are determined by factors linked both to period of death in adulthood and to period of birth providing some support to the foetal ‘programming’ hypothesis for the causation of heart disease.
8.
TaoSHuangZWuXZhouBHaoJLiYCHD and its risk factors in the People's Republic of China. Int J Epidemiol1989; 18: 159–163.
9.
YoshinagaAHoribeH. Serum lipid concentrations in Japanese children: a synthesis of 27 studies. CVD Prevention1998; 1: 55–70.
10.
This paper represents the most systematic review of all studies of serum lipid levels in Japanese children and finds higher mean values for total cholesterol concentration in the more recent time period.
11.
SansSKestelootHKromhoutD. The burden of cardiovascular diseases mortality in Europe. Eur Heart J1997; 18: 1231–1248.
12.
This paper reviews the levels and trends of CVD in Europe using routine mortality data for the period 1970–1992. The important point is made that despite the decreasing mortality rates in western European countries there has been no decrease in the absolute number of people dying from CVD. The increasing trend in CVD mortality in central and eastern European countries is described.
13.
LeonDAChenetLShkolnikovVMZakharovSShapiroJRakhmanovaGHuge variation in Russian mortality rates 1984–1994: artefact, alcohol or what?Lancet1997, 350: 383–388.
14.
The paper describes the mortality experience in Russia in the period 1984–1994 and explores the reason for the increase in mortality in the period from 1987 to 1994.
15.
ZatonskiWAMcMichaelAJPowlesJW. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ1998; 316: 1047–1051.
16.
Tunstall-PedoeHKuulasmaaKAmouyelPArveilerDRajakangasAPajakA. Myocardial infarction and coronary deaths in the World Health Organisation MONICA project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation1994; 90: 583–612.
17.
This paper reports cross-sectional results on coronary event registration from the WHO MONICA project using data for the period 1985–1987. Major differences were found between populations in non-fatal as well as fatal coronary event rates. In particular, the data are used to relate rates of validated CHD deaths to non-fatal myocardial infarction rates across 38 population from 21 countries.
18.
RenaudSde LorgerilM. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet1992; 339: 1523–1526.
19.
BeagleholeRStewartAWJacksonRDobsonAJMcElduffPD'EsteKDeclining rates of coronary heart disease in New Zealand and Australia, 1983–1993. Am J Epidemiol1997; 145: 707–713.
20.
This paper presents the final results of 10 years of monitoring of CHD in the three Australasian MONICA project collaborating centres. Myocardial infarction rates declined significantly in all three centres in parallel with the declining mortality rates. Twenty-eight day case fatality also declined, especially in the two Australian centres.
21.
JacksonRGrahamPBeagleholeRDe BoerGK. Validation of coronary heart disease death certificates diagnoses. NZ Med J1988; 101: 658–660.
22.
BoyleCADobsonAJ. The accuracy of hospital records and death certificates for acute myocardial infarction. Aust NZ J Med1995; 25: 316–323.
23.
ZhaoDGoffDCHerraCRamseyDJChanFAOrtizCEvaluation of the accuracy of coronary heart disease coding on death certificates: The Corpus Christi Heart Project. CVD Prevention1998; 1: 48–54.
24.
BeagleholeRStewartAWWlakerP. Validation of coronary heart disease hospital discharge data. Aust NZ J Med1987; 17: 43–46.
25.
PladevallMGoffDCNichamanMZChanFRamseyDOrtizCAn assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project. Int J Epidemiol1996; 25: 948–952.
26.
McGovernPGPankowJSShaharEDolisznyKMFolsomARBlackburnHRecent trends in acute coronary heart disease, mortality, morbidity, medical care, and risk factors. N Engl J Med1996; 334: 884–890.
27.
This is a recent paper from the long term Minnesota Heart Survey which has been examining trends in CHD mortality and morbidity, medical care, and the CVD risk factor profile of the population of Minneopolis-St Paul. The paper concludes that the decline in CHD mortality in the period 1985–1990 can be explained by both the declining incidence of myocardial infarction in the population and the improved survival of patients with myocardial infarction.
28.
GoldbergRJGorakEJYarzebskiJHosmerDWDalenPGoreJMA communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation1993; 87: 1947–1953.
29.
ChamblessLKeilUDobsonAMahonenMKuulasmaaKRajakangasA. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA project 1985–1990. Circulation1997; 96: 3849–3859.
30.
This paper from the MONICA project provides a population perspective on CHD case fatality patterns using cross-sectional data for the period 1985–1990. Approximately two-thirds of 28-day CHD death in both men and women occurred before hospitalisation. It is clear that opportunities for reducing overall case fatality through improved hospital care are limited.
31.
SonkeGBeagleholeRStewartAJacksonR. Sex differences in case fatality before and after admission to hospital after acute cardiac events: analysis of community based coronary heart disease register. BMJ1996; 313: 853–855.
32.
NorrisRM. Fatality outside hospital from acute coronary events in three British health districts, 1994–1995. BMJ1998; 316: 1065–1070.
33.
BonneuxLLoomanCWNBarendregtJJVan der MassPJ. Regression analysis of recent changes in cardiovascular morbidity and mortality in the Netherlands. BMJ1997; 314: 789–792.
34.
MurrayCJLLopezAD (editors). Global burden of disease. A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Global burden of disease and injury series. Boston: Harvard School of Public Health, WHO and The World Bank, Harvard University Press; 1996.
35.
HuninkMGMGoldmanLTostesonANAMittlemanMAGoldmanPAWilliamsLWThe recent decline in mortality from coronary heart disease, 1980–1990. JAMA1997; 277: 535–542.
36.
This paper, based on a computer-simulation state-transition model of the population of the USA, explores explanations for the decline in CHD mortality in the period 1980–1990. In contrast to earlier estimates, the authors conclude that reductions in primary and secondary risk factors explain about 50% of the decline in CHD mortality and that most of the decline occurred among patients with CHD.
37.
VartiainenEPuskaPPekkanenJTuomilehtoJJousilahtiP. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ1994; 309: 23–27.